β-Glucuronidase inhibitory activity of bromophenol isolated from red alga Grateloupia lancifolia
The Han Nguyen , Patrick Achiever Blamo Jr , Xiaoyong Liu , Thi Van Anh Tran , Sang Moo Kim
AIMS Agriculture and Food ›› 2021, Vol. 6 ›› Issue (2) : 551 -559.
The human gastrointestinal (GI) tract plays an important role in disease and health. The overexpression of β-glucuronidase, an enzyme produced in the gastrointestinal tract, has been found to cause the retoxification of potentially damaging substances already detoxified by liver glucuronidation. Thus, β-glucuronidase has been implicated in a number of diseases including colon cancer, liver disease and Crohn’s disease. This study investigated β-glucuronidase inhibitory activity of a bromophenol purified from the red alga Grateloupia lancifolia. Using an assay-guided fractionation technique, a bromophenol, bis(2,3-dibromo-4,5-dihydroxybenzyl) ether, a bromophenol, was isolated from the red alga G. lancifolia. Its structure was elucidated on the basis of extensive 1D-and 2D-NMR studies, high resolution EI-MS analysis and comparisons with literature data. Bis(2,3-dibromo-4,5-dihydroxybenzyl) ether showed potent β-glucuronidase inhibitory activity. The IC50 and KI values of bromophenol against E. coli β-glucuronidase were 0.54 and 0.53 mM, respectively. This bromophenol inhibited β-glucuronidase competitively and was stable at pH 2 up to 40 min at 37 ℃.
β-glucuronidase inhibitor / bromophenol / Grateloupia lancifolia
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
/
| 〈 |
|
〉 |